TheProfitWatch

BIAF - bioAffinity Technologies, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.91 -0.21 (-7.22%) --- 0.0 (0.0%) -0.01 (-0.37%) -0.08 (-2.75%) -0.08 (-2.86%) -0.08 (-2.85%) -0.08 (-2.85%)

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Category: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.17
Diluted EPS:
-0.17
Basic P/E:
-15.8824
Diluted P/E:
-15.8824
RSI(14) 1m:
0.0
VWAP:
2.7
RVol:

Events

Period Kind Movement Occurred At

Related News